Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02851134

NCT02851134
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease
  • You are part of a family registered in the EPIMAD database that has at least 3 members diagnosed with Crohn's disease

Who may not be able to join:

  • Women who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Lille
Registry
clinicaltrials_gov
Start date
1 April 2015
Est. completion
1 April 2018

Where this trial is recruiting

🇫🇷 France

Primary endpoints

NOD2 gene status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov